Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Triamcinolone Acetonide × Thoracic × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 3 Thoracic 1 Lymphoid 1 Genitourinary 1 Dermatologic 1 CNS 1 Breast 1

Conditions

Lung Neoplasms 1 Exanthema 1

Interventions

Carboplatin 458 Cisplatin 375 Paclitaxel 310 Pemetrexed 298 Docetaxel 241 Erlotinib Hydrochloride 239 Gemcitabine 232 Radiotherapy 170 Bevacizumab 169 pembrolizumab 167 Nivolumab 128 Etoposide 104 Gefitinib 93 Vinorelbine 84 durvalumab 69 atezolizumab 66 Cetuximab 63 Topotecan 60 Drug Therapy 56 Ipilimumab 55 Irinotecan 53 osimertinib 51 Radiosurgery 51 Afatinib 50 Surveys and Questionnaires 37 130-nm albumin-bound paclitaxel 37 Albumin-Bound Paclitaxel 36 Cyclophosphamide 35 Taxes 34 Surgical Procedures, Operative 34

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00473083 2017-04-04

LUTRAERL

British Columbia Cancer Agency

Phase 2 Completed

150 enrolled 13 charts

Exanthema, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡